Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and

Lin Yao1, Peng-Cheng Ye2, Wang Tan3

  • 1Department of Gastrointestinal Surgery, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu 610000, Sichuan Province, China, The Hepatobiliary Research Institute, North Sichuan Medical College, Nanchong 637000, Sichuan Province, China.

Abstract

Insights

Downregulation of the long non-coding RNA HOXD-AS2 promotes gastric cancer (GC) progression by affecting HOXD8 expression and the PI3K/Akt pathway. HOXD-AS2 may serve as a diagnostic biomarker and therapeutic target for GC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) play roles in various cancers, but their specific functions in gastric cancer (GC) remain unclear.
  • Investigating lncRNAs like HOXD-AS2 is crucial for understanding GC development.

Purpose of the Study:

  • To investigate the expression, molecular mechanism, and prognostic significance of HOXD-AS2 in gastric cancer.
  • To determine if HOXD-AS2 can serve as a diagnostic biomarker or therapeutic target for GC.

Main Methods:

  • Real-time quantitative PCR to assess HOXD-AS2 expression in GC tissues and cell lines.
  • In vitro assays (Transwell, wound healing, CCK-8, flow cytometry) to evaluate HOXD-AS2's impact on GC cell proliferation, migration, invasion, cell cycle, and apoptosis.
  • Western blot analysis to explore the regulatory mechanism involving HOXD8 and the PI3K/Akt pathway.

Main Results:

  • Low HOXD-AS2 expression correlated with lymph node metastasis and advanced tumor-node-metastasis stage in GC.
  • Overexpression of HOXD-AS2 inhibited GC cell progression, proliferation, and migration.
  • HOXD-AS2 was found to regulate HOXD8 expression and inhibit the PI3K/Akt signaling pathway.

Conclusions:

  • Downregulation of HOXD-AS2 promotes GC progression by modulating HOXD8 expression and activating the PI3K/Akt pathway.
  • HOXD-AS2 shows potential as a novel diagnostic biomarker and therapeutic target for gastric cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K